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Abstract
Essential hypertension is considered to be a result of the interaction between genetic and 
environmental factors, including perinatal factors. Different advantageous perinatal factors 
proved to have beneficial long-lasting effects against an abnormal genetic background. 
Taurine is a ubiquitous sulphur-containing amino acid present in foods such as seafood. The 
antihypertensive effects of taurine have been reported in experimental studies and in human 
hypertension. We aimed to investigate the effects of perinatal treatment with taurine in 
spontaneously hypertensive rats (SHR), a known model of genetic hypertension. Female 
SHR were administered with taurine (3 g/l) during gestation and lactation (SHR-TAU). 
Untreated SHR and Wistar-Kyoto rats (WKY) were used as controls. Long lasting effects in 
offspring were investigated. Addition of taurine to the mother’s drinking water reduced blood 
pressure in adult offspring. No differences were observed in cardiac hypertrophy. Findings 
on morphometric evaluations suggest that perinatal treatment with taurine would be partially 
effective in improving structural alterations of the aorta Modifications in gene expression of 
Bcl-2 family members and upregulation of endothelial nitric oxide synthase in the aorta of 
22-week-old male offspring were found. No differences were observed on relative telomere 
length in different cardiovascular tissues between SHR and SHR-TAU. Altogether results 
suggest that taurine programming, albeit sex-specific, is associated with gene expression 
changes which ultimately may lead to improvement of aortic remodelling and enhanced 
endothelial function because of augmented nitric oxide (NO) production.
Keywords: hypertension; taurine; spontaneously hypertensive rats, foetal programming, 
endothelial nitric oxide synthase, telomere length
Introduction
Although the hereditary nature of cardiovascular diseases is well established, the perinatal 
origin of adult disease or programming hypothesis has been widely supported by many lines 
of evidence in animal models and human epidemiologic studies(1). Aberrant environmental 
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correlate with arterial hypertension and cardiovascular disease later in life(2,3). Conversely, 
advantageous perinatal factors may have beneficial long-lasting effects against an abnormal 
genetic background. Different strategies have been used during pregnancy and lactation to 
ameliorate the development of hypertension in offspring in Spontaneously Hypertensive 
Rats (SHRs)(4–8), a widely used genetic model of human essential hypertension. Despite 
the genetic predisposition, the perinatal environment seems to play a role in the 
development of blood pressure in SHR.
Taurine (2-aminoethanesulphonic acid) is present in the diet and can also be synthesized 
from cysteine and methionine in the postnatal life. Numerous intracellular and extracellular 
functions have been described for taurine(9–11). Beside its antioxidant activity, which has 
long been recognized(12), it has been demonstrated that taurine acts as an anti-
inflammatory agent(13,14). Taurine has been shown to have a number of essential 
biological functions in vivo. Although taurine is best known for its role in lipid metabolism, is 
also beneficial against a variety of aging-related diseases, such as chronic heart failure, 
diabetes, atherosclerosis, etc(15).Several groups have shown that addition of taurine to the 
drinking water of SHR had an effect on the development of hypertension(16–20). 
Furthermore, in two double-blind, placebo-controlled studies, oral administration of taurine 
decreased blood pressure in borderline hypertensive subjects compared with the placebo-
treated subjects(21,22). In addition, taurine supplementation reduced carotid intima-media 
thickness of pre-hypertensive participants(19).The beneficial effects of taurine on 
hypertension, both in rat experimental models and in cases of human hypertension, have 
been reviewed elsewhere(23). Taurine may be an attractive and cost-effective approach to 
treat hypertension even during pregnancy. Furthermore, taurine-rich food is easily 
consumed daily. Some studies suggested that taurine has a programming effect on 
hypertension(24,25). The purpose of the present study was to determine whether taurine 
administration during pregnancy and lactation would influence 1) systolic blood pressure 
(SBP), 2) aortic geometry, and 3) cardiac hypertrophy in adult (22 weeks old) SHR. 
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There were no differences in maternal body weight during pregnancy and lactation 
[Supplementary Information (SI) 1A] or in obstetrical-neonatal outcomes (SI 1B) between 
SHR and SHR-TAU groups. Perinatal taurine supplementation had no effect on postnatal 
growth (SI 1C).
Body weight in male and female offspring
Body mass was recorded during 19 weeks and no statistical differences were found between 
SHR and SHR-TAU groups in males and females (SI 2).
Systolic Blood Pressure 
As expected, SBP was found to be elevated in SHR with respect to Wistar-Kyoto (WKY) rats 
(P<0.0001 in males and females, Figure 1). Repeated measures ANOVA showed that both 
male and female offspring from mothers on taurine achieved significantly lower SBP (Figure 
1). Planned comparisons were performed and analysis detected decreased SBP in SHR-
TAU with respect to SHR in both male and female especially between weeks 19 and 22.
Geometry of the thoracic aorta
Representative images of transversal aortic slices stained with hematoxylin-eosin are shown 
in SI 3. In line with previous data(26,27), hypertension in SHR led to an increase in the 
cross-sectional area (CSA) of the wall, a thickening of the wall (Wt) and the consequent 
increase in the Wt/lumen ratio (Table 1). Analysis of the effects of perinatal taurine revealed 
a tendency toward statistical significance (P= 0.06) in CSA values in males (Table 1). 
Additionally, CSA/BW values were found to be significantly reduced in aortas from SHR-TAU 
with respect to SHR also in males.
Cardiac and renal hypertrophy
As expected(26,28,29), we found left ventricular hypertrophy in SHR, as heart-to-body 
weight ratio was increased in comparison with WKY in both male [SHR 0.37± 0.02 (n=7) vs. 
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(n=7), P< 0.001]. Perinatal taurine had no effect on the hypertension-induced cardiac 
hypertrophy in mature SHR [male SHR-TAU 0.384±0.01 (n=9) and female SHR-TAU 
0.38±0.01 (n=11)]. The kidney-to-body weight ratio was not different between groups [males: 
SHR 0.37±0.02 (n=7), SHR-TAU 0.38±0.01 (n=9), WKY 0.35±0.01 (n=9); females: SHR 
0.39±0.01 (n=9), SHR-TAU 0.38±0.01 (n=11), WKY 0.33±0.03 (n=7)]. 
Mitochondrial DNA content in the left ventricle 
It has been suggested that the increase in mitochondrial mass and the mitochondrial DNA 
(mtDNA) content are early molecular events of human cells in response to endogenous or 
exogenous oxidative stress(30). It has also been demonstrated in SHR that the total number 
of copies of mtDNA increases as a function of age in the heart(31). Programming of 
oxidative stress in the left ventricle was investigated by measuring mtDNA content (Figure 
2). We found no differences between groups on mtDNA content in the left ventricle at 
weaning or at 22-weeks old. Further analysis detected an effect of age (4 vs. 22- weeks old) 
in SHR, SHR-TAU and WKY (P<0.00001 in all groups).
Relative telomere length in cardiovascular tissues
We hypothesized that perinatal taurine would decrease the oxidative stress and/or the 
hemodynamic stress associated with hypertension, and therefore would prevent 
senescence. As mechanical shear forces induced by blood flow may play different roles in 
the process of vascular remodelling in different vessels, we selected the aortic arch and the 
iliac arteries as conductance (elastic) arteries, and the mesenteric arteries as small 
resistance (muscular) arteries. Perinatal taurine had no significant influence on RTL in 
cardiovascular tissues at adulthood (Figure 3). We determined RTL in aorta and iliac arteries 
at pre-hypertensive age and during established disease (Figure 3). Analyses showed no 
differences between age-matched groups. We further analysed the effect of age on RTL (4 
vs. 22-wo). Only in males and especially in SHR, analysis detected decreased RTL in aortic 
arch with increasing age (P= 0.01). We have also studied RTL in mesenteric arteries; left 
ventricle and kidney at 22-wo but no differences were detected between groups (Figure 3). 
Finally, analysis was performed to assess RTL differences between tissues. RTL was similar 
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4 and 22-wo (SI 4). RTL was found to be increased in iliac arteries, and also in the aortic 
arch, with respect to mesenteric arteries in WKY and SHR-TAU at 22-wo, but not in SHR 
where no differences in RTL were found, suggesting decreased intrinsic cell turnover in 
resistance arteries in SHR. RTL in left ventricle was decreased with respect to kidney in all 
groups at 22-wo.
Gene expression in the aortic arch and in the left ventricle
We examined whether the expression of telomerase reverse transcriptase (Tert) was 
influenced by perinatal taurine in the aorta at 4 (pre-hypertensive stage) and 22 weeks after 
birth (Figure 4). The expression of mRNA Tert in SHR was not different to WKY. However, 
specifically in males, the expression of Tert was increased in the aorta of 22-wo SHR-TAU 
(P= 0.02). Programming of aortic senescence was investigated by measuring cyclin-
dependent kinase inhibitor 2A (p16Ink4a) mRNA expression(32). It has been previously 
hypothesized that hypertension-induced increases in p16INK4a expression could result in a 
widespread irreversible cell cycle arrest with accumulation of senescent cells(28). Analysis 
showed no significant differences between groups (Figure 4).
An altered balance between proliferation and death has been proposed to be a determinant 
of vascular, renal, and cardiac remodelling in genetic hypertension(33–35). We were then 
intended to unravel if perinatal taurine may lead to changes in mRNA expression of BCL2-
associated X protein (Bax) and B-cell leukemia/lymphoma protein-2 (Bcl-2) in the aortic arch 
as a consequence of alteration of the perinatal environment (Figure 4). Results showed that 
the Bax/Bcl-2 mRNA ratio was decreased in male SHR compared to male WKY (P= 0.0006). 
Interestingly, the effects of perinatal taurine were significant but in different directions in male 
(P= 0.0003) and female (P= 0.02) offspring. To further explore this sexual dimorphism, we 
measured the expression of p53 tumor suppressor (p53) in both SHR and SHR-TAU groups 
(Figure 4), and analysis detected a marked sexual dimorphism in the levels of p53: p53 
mRNA expression was found to be higher in male (P= 0.006) and lower in female SHR-TAU 
aortic homogenates (P= 0.02).
We then aimed to investigate if perinatal taurine may program enhanced NO bioavailability 
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Planned comparisons indicated a down-regulation of eNOS in male SHR with respect to 
WKY in adulthood (P= 0.004). Taurine supplementation during gestation and lactation in 
SHR increased the transcript levels of eNOS in males (P= 0.01). The mRNA expression of 
antioxidant enzymes was measured to indirectly assess changes in the oxidative status 
programmed by perinatal taurine (Figure 4). Among the different antioxidant molecules, SOD 
and catalase mutually function as important enzymes in the elimination of reactive oxygen 
species. A differential expression between SHR and WKY in 22-wo aorta was detected only 
in the levels of superoxide dismutase 3 (SOD3 or EC-SOD). The transcript level of SOD3 
was significantly downregulated at 22-wo in female SHR (P= 0.03). On the other hand, 
perinatal taurine had no effect on the expression of superoxide dismutase 2 (SOD2 or Mn-
SOD), SOD3 or catalase.
Differences between groups at weaning failed to achieve statistical significance (data not 
shown, N male / female 4-wo offspring: 6-7 / 4 SHR, 5-8 / 5-9 SHR-TAU, 5-7 / 5 WKY).
Perinatal taurine had no significant influence on gene expression of Tert, p16Ink4a, Bax/Bcl-
2, SOD2, SOD3 or catalase in the left ventricle in SHR in adulthood (SI 5).
Discussion
Our research shows that maternal taurine supplementation (3 g/l) during pregnancy and 
lactation is associated with a reduction in SBP in adult offspring. Of note, although treatment 
with taurine significantly reduced SBP in SHR, it remained elevated compared to that in 
WKY rats.
Findings on morphometric evaluations suggest that perinatal treatment with taurine, when 
initiated in utero, would be partially effective in improving structural alterations of the aortic 
artery. Decreased cardiac(17,20,36) and renal(20) hypertrophies in taurine-treated SHRs 
has been previously demonstrated, reinforcing the notion that the blood pressure- lowering 
effect of taurine also led to a decrease in hypertension-induced organ hypertrophy. 
However, according to our results, perinatal exposure to taurine has no benefits on end 
organ structure of the heart and kidney in SHR. In accordance, it was formerly reported that 
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Several studies have shown that senescence can be triggered either by telomeric DNA 
instability resulting from telomere erosion (replicative senescence) or following exposure to 
multiple types of stress (stress-induced senescence), such as oxidative stress and DNA 
damage(37). We have anteriorly shown through meta-analysis that leukocyte telomere 
length (LTL), a novel biomarker for age and age-related diseases, is shorter in hypertensive 
than in normotensive individuals(38). Because offspring had no contact with taurine from the 
time point of weaning, changes in SBP represents long lasting effects. We proposed that 
exposure to taurine in the intrauterine and postnatal period may lead to permanent 
modifications such as changes in telomere length in target tissues. RTL in cardio-vascular 
tissues from perinatally supplemented SHR showed no difference with respect to control 
SHR. However, according to our results, maternal taurine treatment was associated with an 
increase in Tert gene expression in aorta, at least in males at 22-wo. Some studies have 
shown effects of taurine on telomere length, e.g. the average RTL measured by RT-PCR in 
livers of aging mice was positively correlated with blood levels of taurine(39). In rabbits, 
taurine treatment diminished the intimal hyperplasia associated with oxidative stress in iliac 
arteries, while also partially reversed the decrease in telomere shortening(37). Telomere 
size may play a prominent role in the etiology of arterial vascular remodelling in genetic 
hypertension; however, we were not able to detect changes in RTL or in the transcript levels 
of Tert in SHR.
Growth, apoptosis, low-grade inflammation, and vascular fibrosis are all dynamic processes 
that have been invoked to contribute to arterial remodelling in hypertension(40). Xiao F et al 
have reported increased Bcl-2/Bax mRNA and protein ratios in the aortic vascular smooth 
muscle cells (SMCs) of SHR aged 16-wo(41). However; data about Bax and Bcl-2 in the 
aorta are scarce and potentially controversial(38). It has been suggested that 
antihypertensive therapy may contribute to regression of vascular wall growth via activation 
of pro-apoptotic mechanisms(26,40,42).The correction of aortic SMC hyperplasia may 
contribute to the normalization of mechanical properties of the vessel wall, therefore 
restoring vascular compliance of conductance arteries(42). Accordingly, increased Bax/Bcl-2 
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was previously described(26). Furthermore, apoptosis in SMCs is enhanced transiently 
during the regression of aortic hypertrophy in SHR treated with different classes of 
antihypertensive drugs(43,44). Losartan induced a synchronous wave of apoptosis in SMCs, 
as evidenced e.g. by a transient increase in Bax/Bcl-2 ratio(45). In the present study, both 
Bax/Bcl-2 ratio and p53 were increased in SHR-TAU males, suggesting that the beneficial 
effect on blood pressure of perinatal supplementation with taurine in male SHR may be in 
part a result of vascular hypertrophy regression. In females, exposure to taurine from 
conception until weaning has shown to decrease both Bax/Bcl-2 ratio and p53 expression in 
the aortic arch. The mechanisms of the sexual dimorphism involved in the observed 
changes in Bax/Bcl-2 mRNA ratio and p53 mRNA are unclear; however, beyond marked 
sexual dimorphism, perinatal taurine through programming would prevent the decrease in 
Bax/Bcl-2 ratio in SHR. In a recent study, Liang W et al reported that 3% taurine attenuated 
the progression of vessel wall injury, and promoted the apoptosis of vascular SMCs via up-
regulation of Bax protein and down-regulation of Bcl-2 protein(46). Further analyses are 
necessary to study the role of perinatal taurine on apoptosis in arterial walls.
Nitric oxide (NO), generated within vascular endothelium by eNOS, is the principal agent 
that regulates blood pressure by causing relaxation of vascular SMCs in conduit arteries(47). 
Our results were in accordance with previous reports. The expression of eNOS transcript in 
aorta of 25-wo male SHR, tested by quantitative RT-PCR, has previously probed to be 
decreased with respect to WKY(48). Concerning the mechanism through which perinatal 
taurine may act it is surely multifactorial, nonetheless putative mechanisms whereby 
perinatal taurine improve oxidative stress may be due to 1) an ability to regulate NO 
synthases that generate NO; 2) an ability to regulate enzymes such as NAD(P)H oxidase 
that generate free radicals; or 3) an ability to regulate antioxidant enzymes, including SODs, 
which metabolize free radicals. In the present study, eNOS gene expression in the aorta was 
affected by perinatal taurine, suggesting that this sulphur amino acid may increase NO 
production, thereby contributing to the prevention of endothelial dysfunction and 
hypertension. A beneficial effect of taurine has been formerly described in aortas from 
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perinatal taurine supplementation on the endothelium-dependent vasodilation. On the other 
hand, our results revealed that the beneficial effects of taurine supplementation appear not 
to be related to programmed antioxidant activity. Of note, in the present study perinatal 
taurine has shown to up-regulate both Tert and eNOS gene expression. A relationship 
between Tert expression and activity and eNOS/NO activation has been previously 
described(50–52).
The present study has some limitations that should be taken into consideration before 
drawing conclusions. The failure to reach significance in secondary outcomes could possibly 
be a type 2 error due to the limited sample size and sex-specific effects. Some maternal 
effects seem to be sex specific, suggesting a possible role of sex hormones, particularly 
oestrogen, in these effects. It was previously demonstrated that taurine can promote the 
secretion of prolactin, follicle-stimulating hormone and luteinizing hormone in female rats, 
also stimulating the levels of oestrogen and progesterone (53). Previous studies have shown 
gender-specific effects of maternal taurine supplementation (54–58). Koeners MP et al have 
found a more pronounced antihypertensive effect of perinatal treatment with a mixture of 
micronutrients, including taurine, in male than in female genetically hypertensive rats (58). It 
has been hypothesized that oxidative stress may not be as important in mediating 
hypertension in female as in male rats (59). Further studies of the mechanisms underlying 
sexual dimorphism are of substantial significance for the development of gender-specific 
strategies to ameliorate or prevent disease later in life. On the other hand, since alterations 
in mRNA levels may not necessarily reflect changes in corresponding proteins, further 
studies are required to hypothesis testing. Finally, through the current study design it is not 
possible to determine if the observed effects are a consequence of the decrease in maternal 
blood pressure during pregnancy and lactation or a consequence of direct or indirect effects 
on the fetus or on pre-weaning offspring. Maternal blood pressure certainly could play a role. 
Available data suggest that the hypotensive effect of taurine does not occur through one 
specific mechanism but rather through multiple mechanisms(22). On the other hand, it is 
also possible that taurine would have a beneficial effect on other maternal outcomes. More 
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programming. Taurine supplementation has been proposed to play a role in mediating 
inflammatory processes in SHR(60). It is therefore possible that the beneficial effects of 
perinatal taurine may be also attributed to anti-inflammatory actions on maternal or neonatal 
metabolic parameters.
Although SHR have responded only moderately to perinatal taurine treatment, our findings 
supports the possibility of improving the genetically hypertensive state by manipulating the 
early environment. In males, the blood pressure lowering effects of taurine supplementation 
appear to be related, at least in part, to the upregulation of eNOS and increased 
programmed apoptosis. Because of the long-lasting effect of maternal taurine treatment on 
gene expression, our future directions are to examine for epigenetic changes that are 
influenced by perinatal taurine. A recent study has shown that maternal treatment of SHR 
with pentaerythritol tetranitrate during the pregnancy and lactation periods leads to a 
persistent blood pressure reduction in the offspring, which was associated with upregulation 
of eNOS, SOD2, GPx1, and HO-1 and modifications in the promoter regions of eNOS, 
SOD2 and HO-1genes(8).
Unravelling the plethora of mechanisms resulting in the programming phenomenon could 
lead to simple maternal interventions aimed to ameliorate both increasing prevalence of 
common diseases and public health costs.
Methods
Information concerning experimental animals and ethical statement is available at SI 6.
Experimental design
After acclimatization for one week, adult (12-wo) virgin SHR females were randomly divided 
into two experimental groups: SHR and SHR-TAU. SHR-TAU dams received taurine (3 g/l) 
in drinking water (n= 12) from the time point of mating to the end of the lactation period. 
Untreated SHR (n= 10) and WKY rats (n= 8) were used as controls. Dams were housed in 
individual cages except during mating. Water intake was monitored across pregnancy and 
lactation periods in order to ensure that the daily drug intake was consistent across each 
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Pups were culled to 6-8 after birth. Offspring’s body weights were measured daily until 
weaning and weekly until termination of the experiment. SBP was measured once a week by 
indirect tail-cuff method using a sphygmomanometer as previously described(61). The first 
measurement was performed at 13-wo after a period of 4 weeks of acclimation. Each weekly 
value corresponds to at least 3 independent measurements taken in a 5 minute period. Rats 
were intensively handled and trained in order to reduce stress as much as possible. Fasting 
animals were euthanized at 4 or 22 weeks via cervical dislocation and decapitation. Right 
kidneys were isolated, dried and weighed to calculate the kidney weight / body weight ratio. 
Heart was also excised and weighed and the cardiac hypertrophy index was calculated 
dividing the heart weight by the body weight in each animal. The left ventricle was isolated 
leaving the interventricular septum as an integral part of the left ventricle. The aortic arch, 
the iliac and mesenteric arteries were also excised and cleaned of adhesive fat and 
connective tissue. All tissues were quickly snap-frozen and stored in −76◦C until nucleic acid 
extraction. A portion of the thoracic aortic was fixed in 10% formalin for morphometry 
analysis.
Aortic morphometry analysis
Fixed thoracic aortic segments were embedded in paraffin and cut into traversal 5 µm-thick 
slices that were stained with hematoxylin and eosin. Images were obtained with a 
microscope (Olympus BX50) coupled to an adapted camera (Olympus DP50). 
Morphometrical analysis was performed by two different blinded operators using Scion 
Image 4.2 for Windows software. Three slides with 5 semi-serial (1 section every 25 µm) 
sections each, i.e. a total of 15 sections, were obtained from each sample. Analysis and 
calculations included the determination of lumen, CSA, wall thickness (Wt) and the ratio of 
the wall thickness to the lumen diameter (Wt/lumen). 
RNA preparation and Real Time PCR for quantitative assessment of mRNA 
expression
We investigated mRNA expression of genes encoding Bcl-2, Bax, p53, eNOS, SOD2, 
SOD3, catalase, Tert and p16Ink4a. Total RNA was extracted with the use of the modified 
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suspended in RNase-free water, and the RNA concentration was quantified by measuring 
the absorbance at 260 nm in a nanodrop (Nanodrop ND-1000, Thermo Fisher Scientific 
Inc.). cDNA synthesis was performed by RT-PCR using 1-3µg of mRNA template, the 
Moloney Murine Leukemia Virus (Easy Script Reverse Transcriptase M-MLV, RNAse H-) 
Reverse Transcriptase and oligo(dT) primers according to manufacturer’s protocol. PCRs 
were performed in a 7500 Real-Time PCR System (Applied Biosystems) using the KAPA 
SYBR® FAST qPCR Kit Master Mix (2×) Universal (Kapa Biosystems) and following the 
manufacturer’s instructions. Each RT-PCR quantification experiment was performed in 
duplicate and all samples were tested blind to the experimental groups. The relative 
abundance of the target gene mRNA was normalized to the amount of a housekeeping gene 
[beta-2 microglobulin (B2m)] to carry out comparisons between the groups SI 8A. Specific 
primers are shown in SI 8B.
DNA isolation and measurements of relative telomere length
An assay based on real-time quantitative PCR was used for RTL measurement based on a 
method that uses a ratio of telomere DNA signal intensity to single-copy gene signal 
intensity (SI 8C)(63). DNA was isolated from frozen tissues using a sequential nucleic acid 
extraction method developed in our lab (full protocol available under request). DNA 
concentration was measured with a spectrophotometer and samples were diluted to a 
concentration of 10 ng/μL. mtDNA content was also estimated as described in SI 8D.
Statistical analysis
Our primary outcomes were: 1) change in SBP, 2) change in cardiac hypertrophy, and 3) 
change in aortic morphometry between SHR and SHR-TAU. Sample size was sufficient to 
detect a 12% difference with 80% power. Values are expressed as mean ± SEM to estimate 
the population mean from the sample data. All statistical analyses were carried out using the 
Statistica program package V7.0. Analyses were performed separately in each sex. Bartlett 
test was used to determine the homogeneity of variances and the Kolmogorov-Smirnov 
normality test was used to examine if variables were normally distributed. One-way analysis 
of variance (ANOVA) was employed to compare the means of three or more independent 
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The nonparametric Kruskal-Wallis test was used when the assumptions of normality of 
ANOVA were not met. For SBP analysis, the effects of blood pressure and the effects of 
perinatal taurine were separately analysed by the Kruskal-Wallis ANOVA test and ANOVA 
for repeated measurements respectively. A nominal significance threshold of P= 0.05 (two-
sided) was set for all analyses(64).
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Table 1 Morphometric parameters in the thoracic aorta at 22-weeks old
males females
SHR SHR-TAU WKY SHR SHR-TAU WKY
Lumen 1629.00±17.80 1581.74±14.19 1526.03±54.35 * 1399.86±20.89 1357.55±18.73 1267.19±34.49 **
Wt 152.08±2.54 142.11±4.78 95.20±7.94 ** 118.92±2.49 120.76±3.76 88.93±1.59 ***
Wt/lumen 9.34±0.15 8.99±0.31 6.31±0.73 *** 8.5148±0.27 8.90±0.23 7.032±0.19 ***
CSA 859.00±24.29 785.69±26.41 # 502.16±26.19 *** 583.99±12.95 568.21±22.56 388.21±12.89 ***
CSA/BW 2.16±0.05 1.88±0.05 ** 1.22±0.06 *** 2.49±0.09 2.38±0.09 1.70±0.10 ***
Footnote: Lumen (µm), wall thickness (Wt, µm), Wt/lumen, cross-sectional area x1000 (CSA, 
mm2) and CSA/ body weight (CSA/BW, mm2/mg) in SHR, SHR-TAU and WKY are shown as 
mean ± SEM. Planned contrasts (vs. SHR) showing differences are indicated as follows: * 
P<0.05, ** P<0.01, *** P<0.001. # indicates P=0.06. N male / female offspring: 5 / 5 SHR, 5 / 
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Figure legends
Figure 1 Systolic Blood Pressure
Footnote: SBP was registered from week 13 after a period of acclimation in SHR (circle), 
SHR-TAU (square) and WKY (triangle). Planned contrasts (SHR vs. SHR-TAU) showing 
differences are indicated as follows: * P<0.05 and ** P<0.01. Data are plotted as mean ± 
SEM. N male / female offspring: 7 / 7-9 SHR, 8-9 / 10-11 SHR-TAU, 9 / 6-7 WKY.
Figure 2 mtDNA content in the left ventricle
In Figure: mtDNA in SHR (black), SHR-TAU (grey) and WKY (white) is plotted as the mean 
± SEM. Analyses were performed separately in each sex. Planned contrasts (4 vs. 22-wo) 
showing statistical differences are indicated with an asterisk. Significant level was taken at 
P<0.05. N 4-wo offspring: 10 SHR, 9 SHR-TAU, 8 WKY. N 22-wo offspring: 9 SHR, 9 SHR-
TAU, 10 WKY.
Figure 3 Relative telomere length
Footnote: Relative telomere length (RTL) in SHR (black), SHR-TAU (grey) and WKY (white) 
is plotted as mean ± SEM. Planned contrasts (4 vs. 22-wo) showing statistical differences 
are indicated with an asterisk. N male / female 4-wo offspring: 7-8 / 6-8 SHR, 10 / 9-10 SHR-
TAU, 5-7 / 6-7 WKY. N male / female 22-wo offspring: 6-7 / 7-9 SHR, 7-8 / 9-11 SHR-TAU, 9 
/ 6-7 WKY.
Figure 4 Gene expression in the aortic arch
Footnote: The data in SHR (black), SHR-TAU (grey) and WKY (white) is plotted as mean ± 
SEM. Contrasts (vs. SHR) showing differences are indicated as follows: * P<0.05, ** P<0.01, 
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